CompaniesRanked

2874 companies · fiscal year 2025 · SEC EDGAR · September 25, 2026

Largest healthcare companies by shareholders' equity — page 3

Ranks 201–288 of 288 · Fiscal year 2025 · Data as of September 25, 2026

Shareholders' equity
#CompanyShareholders' equityYoY15-year trend
201Procept BioroboticsPRCTUS$366M−9.0%
202SchrodingerSDGRUS$364M−13.6%
203VericelVCELUS$355M+21.5%
204Stoke TherapeuticsSTOKUS$352M+53.9%
205OrthopediatricsKIDSUS$347M−2.2%
206Staar SurgicalSTAAUS$344M−13.4%
207Tarsus PharmaceuticalsTARSUS$343M+53.0%
208NovocureNVCR$340M−5.5%
209Cresco LabsCRLBFUS$340M−28.3%
210Phibro Animal HealthPAHCUS$332M+34.7%
211Vanda PharmaceuticalsVNDAUS$327M−39.2%
212Cadre HoldingsCDREUS$318M+2.0%
213Mirum PharmaceuticalsMIRMUS$315M+39.5%
214Clover Health InvestmentsCLOVUS$309M−9.5%
215Genedx HoldingsWGSUS$308M+25.7%
216Vireo GrowthVREOFUS$307M+453.9%
217Keros TherapeuticsKROSUS$303M−47.0%
218CaredxCDNAUS$303M−19.9%
219Collegium PharmaceuticalCOLLUS$302M+31.8%
220HeartflowHTFLUS$301M+$1.2B
221Organogenesis HoldingsORGOUS$300M+14.2%
222Strata Critical MedicalSRTAUS$279M+25.7%
223Pharming GroupPHARNL$277M+25.4%
224RxsightRXSTUS$276M−2.0%
225KamadaKMDAIL$269M+3.7%
226Innovage HoldingINNVUS$257M+3.4%
227Mimedx GroupMDXGUS$257M+32.9%
228SBC Medical GroupSBCUS$248M+27.3%
229Monte Rosa TherapeuticsGLUEUS$233M+4.5%
230Omada HealthOMDAUS$230M+$614M
231Tactile Systems TechnologyTCMDUS$219M+1.1%
232Adaptive BiotechnologiesADPTUS$219M+7.9%
233Guardian Pharmacy ServicesGRDNUS$218M+45.3%
234Maravai LifesciencesMRVIUS$212M−34.7%
235Aveanna HealthcareAVAHUS$194M+$318M
236InogenINGNUS$192M+10.6%
237Arcutis BiotherapeuticsARQTUS$189M+20.3%
238BioventusBVSUS$184M+24.4%
239Alignment HealthcareALHCUS$179M+79.5%
240Si-BoneSIBNUS$178M+6.3%
241AngiodynamicsANGOUS$176M−5.6%
242ArdelyxARDXUS$167M−3.7%
243Natures Sunshine ProductsNATRUS$162M+0.3%
244Tandem Diabetes CareTNDMUS$155M−41.0%
245Irhythm HoldingsIRTCUS$153M+68.0%
246DocgoDCGOUS$144M−55.1%
247Viemed HealthcareVMDUS$142M+7.7%
248Rhythm PharmaceuticalsRYTMUS$139M+540.0%
249Puma BiotechnologyPBYIUS$130M+41.5%
250Lakeland IndustriesLAKEUS$129M−11.9%
251AxogenAXGNUS$129M+24.0%
252Agilon HealthAGLUS$127M−73.1%
253ValnevaVALNFR$125M−33.8%
254TalkspaceTALKUS$117M−0.3%
255Travere TherapeuticsTVTXUS$115M+94.4%
256InotivNOTVQUS$109M−35.8%
257RegenxbioRGNXUS$103M−60.4%
258Axsome TherapeuticsAXSMUS$88.3M+54.9%
259VaxartVXRTUS$87.8M+49.0%
260Airsculpt TechnologiesAIRSUS$87.7M+12.2%
261Treace Medical ConceptsTMCIUS$87.3M−22.6%
262Elite PharmaceuticalsELTPUS$80.3M+120.4%
263Niagen BioscienceNAGEUS$76.5M+66.0%
264Glass House BrandsGLASUS$73.9M−36.4%
265Natural Alternatives InternationalNAIIUS$67.0M−15.3%
266Syndax PharmaceuticalsSNDXUS$64.6M−77.6%
267CerusCERSUS$64.2M+14.4%
268Skinhealth SystemsSKINUS$61.1M+17.9%
269Infusystem HoldingsINFUUS$57.3M−0.4%
270MacrogenicsMGNXUS$55.6M−52.1%
271AccurayARAYUS$53.4M+11.5%
272HarrowHROWUS$52.4M−24.7%
273Xtant MedicalXTNTUS$51.0M+18.6%
274MarimedMRMDUS$50.0M−14.6%
275Halozyme TherapeuticsHALOUS$48.8M−86.6%
276LiquidiaLQDAUS$44.7M−43.6%
277AnaptysbioANABUS$37.2M−47.5%
278LifevantageLFVNUS$33.0M+10.4%
279Petmed ExpressPETSUS$32.8M−65.9%
280Akebia TherapeuticsAKBAUS$32.6M+$81.8M
281Establishment LabsESTAVG$23.5M−55.7%
282LifemdLFMDUS$23.2M+$32.2M
283NeuroneticsSTIMUS$22.4M−19.2%
284Heron TherapeuticsHRTXUS$14.3M+$48.0M
285NRC HealthNRCUS$14.0M−55.3%
286Xeris BiopharmaXERSUS$13.7M+$43.3M
287Alphatec HoldingsATECUS$12.4M+$26.6M
288Nasus PharmaNSRXIL$2.8M+$6.0M

All figures from SEC filings · FY2025 · 88

see sources

Download this data as a CSV →

Largest companies by shareholders' equity →

By sector

By country